Page last updated: 2024-11-13

monoperoxysulfate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

monoperoxysulfate: RN given refers to mono-Na salt [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID23667637
MeSH IDM0194215

Synonyms (8)

Synonym
virkon
28831-12-1
sodium peroxysulfate
peroxymonosulfuric acid, monosodium salt
monoperoxysulfate
sodium;oxido hydrogen sulfate
sodium 2-sulfodioxidan-1-ide
DTXSID20951469

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" The ease and rate of absorption of fluids by these formulations decreased as the fluid consistency increased and they seem more suitable for watery spills than for blood."( Powders, composed of chlorine-releasing agent acrylic resin mixtures or based on peroxygen compounds, for spills of body fluids.
Coates, D; Wilson, M, 1992
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (59)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's23 (38.98)18.2507
2000's16 (27.12)29.6817
2010's15 (25.42)24.3611
2020's5 (8.47)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 40.53

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index40.53 (24.57)
Research Supply Index4.29 (2.92)
Research Growth Index4.47 (4.65)
Search Engine Demand Index91.05 (26.88)
Search Engine Supply Index3.00 (0.95)

This Compound (40.53)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.39%)6.00%
Case Studies1 (1.39%)4.05%
Observational0 (0.00%)0.25%
Other70 (97.22%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]